Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 12/20 | 0.64 |
| ▸ | NPBWR1 | P48145 | 4/20 | 0.64 |
| ▸ | CCKBR | P32239 | 2/20 | 0.61 |
| ▸ | MC4R | P32245 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18556710 | 0.97 | IL23R (0.63) | IL23RNPBWR1CCKBRMC4R | |
| SCHEMBL18556748 | 0.97 | CCKBR (0.64) | IL23RNPBWR1CCKBRMC4R | |
| SCHEMBL12094775 | 0.95 | IL23R (0.59) | IL23RNPBWR1CCKBRMC4R | |
| SCHEMBL12094766 | 0.94 | IL23R (0.62) | IL23RNPBWR1MC4R | |
| SCHEMBL12094739 | 0.93 | MC4R (0.59) | IL23RNPBWR1CCKBRMC4R | |
| SCHEMBL12094803 | 0.93 | MC4R (0.62) | IL23RCCKBRMC4R | |
| SCHEMBL12094761 | 0.93 | MC4R (0.62) | IL23RCCKBRMC4R | |
| SCHEMBL12094778 | 0.93 | MC4R (0.62) | IL23RCCKBRMC4R | |
| SCHEMBL12094740 | 0.93 | MC4R (0.62) | IL23RCCKBRMC4R | |
| SCHEMBL12094763 | 0.93 | MC4R (0.62) | IL23RCCKBRMC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES INC (US) | 2017-05-25 | — | — | US | disclosed |
| US-9580466-B2 | Melanocortin-1 receptor-specific linear peptides | PALATIN TECHNOLOGIES, INC. (US) | 2017-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC5R, MC3R | IL23R 466/4885NPBWR1 69/4885CCKBR 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.